Protalix BioTherapeutics (PLX) Reports Q1 Loss of $0.48/Shre

Go back to Protalix BioTherapeutics (PLX) Reports Q1 Loss of $0.48/Shre
PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.75 +0.06 (2.23%)
Previous Close $2.69    52 Week High $1.11 
Open $2.71    52 Week Low $0.41 
Day High $2.78    P/E N/A 
Day Low $2.69    EPS $-0.29 
Volume 470,954